150 related articles for article (PubMed ID: 30703069)
1. A high mucosal blocking score is associated with HIV protection.
Girard A; Rallón N; Benito JM; Jospin F; Rodriguez C; Chanut B; Benjelloun F; Del Romero J; Verrier B; Lucht F; Pin JJ; Genin C; Biasin M; Clerici M; Paul S
AIDS; 2019 Mar; 33(3):411-423. PubMed ID: 30703069
[TBL] [Abstract][Full Text] [Related]
2. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN).
Hong P; Ninonuevo MR; Lee B; Lebrilla C; Bode L
Br J Nutr; 2009 Feb; 101(4):482-6. PubMed ID: 19230080
[TBL] [Abstract][Full Text] [Related]
3. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
[TBL] [Abstract][Full Text] [Related]
4. Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.
Chen Y; Hwang SL; Chan VS; Chung NP; Wang SR; Li Z; Ma J; Lin CW; Hsieh YJ; Chang KP; Kung SS; Wu YC; Chu CW; Tai HT; Gao GF; Zheng B; Yokoyama KK; Austyn JM; Lin CL
PLoS Pathog; 2013 Jan; 9(1):e1003100. PubMed ID: 23382671
[TBL] [Abstract][Full Text] [Related]
5. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
[TBL] [Abstract][Full Text] [Related]
6. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
8. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
[TBL] [Abstract][Full Text] [Related]
10. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3.
Su SV; Hong P; Baik S; Negrete OA; Gurney KB; Lee B
J Biol Chem; 2004 Apr; 279(18):19122-32. PubMed ID: 14970226
[TBL] [Abstract][Full Text] [Related]
11. Sugar and spice: viral envelope-DC-SIGN interactions in HIV pathogenesis.
Su SV; Gurney KB; Lee B
Curr HIV Res; 2003 Jan; 1(1):87-99. PubMed ID: 15043214
[TBL] [Abstract][Full Text] [Related]
12. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination.
Du T; Hu K; Yang J; Jin J; Li C; Stieh D; Griffin GE; Shattock RJ; Hu Q
Antimicrob Agents Chemother; 2012 Sep; 56(9):4640-9. PubMed ID: 22687513
[TBL] [Abstract][Full Text] [Related]
15. Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120.
Hong PW; Nguyen S; Young S; Su SV; Lee B
J Virol; 2007 Aug; 81(15):8325-36. PubMed ID: 17522223
[TBL] [Abstract][Full Text] [Related]
16. Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
Borggren M; Repits J; Kuylenstierna C; Sterjovski J; Churchill MJ; Purcell DF; Karlsson A; Albert J; Gorry PR; Jansson M
Retrovirology; 2008 Mar; 5():28. PubMed ID: 18371209
[TBL] [Abstract][Full Text] [Related]
17. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
18. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
[TBL] [Abstract][Full Text] [Related]
19. A division of labor: DC subsets and HIV receptor diversity.
Kavanagh DG; Bhardwaj N
Nat Immunol; 2002 Oct; 3(10):891-3. PubMed ID: 12352961
[No Abstract] [Full Text] [Related]
20. Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection.
Hirbod T; Kaldensjö T; Lopalco L; Klareskog E; Andersson S; Uberti-Foppa C; Ferrari D; Manghi M; Andersson J; Loré K; Broliden K
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):239-47. PubMed ID: 19363450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
